15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation
about
Endogenous Generation and Signaling Actions of Omega-3 Fatty Acid Electrophilic DerivativesAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAsBiosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acidA re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neuronsRedox-dependent anti-inflammatory signaling actions of unsaturated fatty acidsAnalysis of estrogens in serum and plasma from postmenopausal women: past present, and futureNovel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ.Targeted chiral lipidomics analysis of bioactive eicosanoid lipids in cellular systems.11-Oxoeicosatetraenoic acid is a cyclooxygenase-2/15-hydroxyprostaglandin dehydrogenase-derived antiproliferative eicosanoid.Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid.Analysis of endogenous glutathione-adducts and their metabolites.Stable-isotope dilution LC–MS for quantitative biomarker analysis.15-oxoeicosatetraenoic acid mediates monocyte adhesion to endothelial cell.Hypoxia activates 15-PGDH and its metabolite 15-KETE to promote pulmonary artery endothelial cells proliferation via ERK1/2 signalling.Hematopoietic stem cell function requires 12/15-lipoxygenase-dependent fatty acid metabolism.Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.15-Oxoeicosatetraenoic acid is a 15-hydroxyprostaglandin dehydrogenase-derived electrophilic mediator of inflammatory signaling pathways.Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acidsStable isotope dilution liquid chromatography/mass spectrometry analysis of cellular and tissue medium- and long-chain acyl-coenzyme A thioestersActivation of transcription factor Nrf2 signalling by the sphingosine kinase inhibitor SKI-II is mediated by the formation of Keap1 dimers.15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids.Formation and signaling actions of electrophilic lipids15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma.New families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions.12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis.Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion.Metabolite identification and quantitation in LC-MS/MS-based metabolomics.Targeted chiral analysis of bioactive arachidonic Acid metabolites using liquid-chromatography-mass spectrometry.Coenzyme A thioester formation of 11- and 15-oxo-eicosatetraenoic acid.Utility of 15(S)-HETE as a Serological Marker for Eosinophilic Esophagitis
P2860
Q26784513-718FA50B-1D95-458A-93A4-511F7CDF08ADQ27014988-4A5DCF69-971E-4CAF-A11C-BE58FDC246BEQ28252674-0020CC2F-B2DD-41B4-AA3A-770E2032A808Q28272440-4D49586A-120A-434B-8044-E9BB65EA3873Q28386488-DD0E4A89-0199-488F-AA6D-A000958055E3Q30432877-DA514496-DCB8-411F-BEE2-3149CBAB3B02Q30573092-72AC35C4-3A91-4883-B6ED-A5ED8C6E8F2CQ33443229-B92B38BE-CFC8-4009-94E0-B5E2403ECB50Q33451846-A4FE64A7-2120-4D00-8F48-2D15BB55C30CQ33458922-DBEFE76B-FBF9-4FB1-92D6-1B25AC712C13Q33519106-31C42AA4-40EA-41D9-B36B-FAC6F08DE541Q33747062-C09E0493-48F1-4B46-888B-A2DAAE0402D7Q33901512-EDACF940-8374-4F23-A0E9-642E33E79081Q33929749-60067E47-9660-4D16-AEB6-12E337672B28Q33931743-4C7D4F06-3D92-4167-9675-59254259F1DAQ34113615-A084A01E-FE88-4A5C-8EF5-C05EE379B82EQ34450882-DDE89421-7B46-479D-A56F-C95594D67F82Q34800981-B582DD9D-0DB5-4F5B-90B4-ED21E451CBCAQ34857863-799589BA-92A4-456E-A89F-233A85B96168Q35088548-86912F2E-01C5-4B0C-ADBE-B0F27400F7D9Q35126717-705F85DB-B6A3-402C-BED3-D4C97BD50C62Q35804051-4D51726E-A2F0-49C4-A62C-3E09A935AEB4Q35813184-D292609E-BAEE-4642-9409-F884AD561496Q36220711-440DEB72-0293-4C53-8239-BDE88EFD68AAQ37451190-222FCF6C-BCE4-4CD9-AD25-E4CC808727D6Q37677259-7485696C-6DCC-40F8-A5B8-F9FCA210E8AEQ37985821-F93AF4E8-787C-4FE4-8BE8-7D36D3FE83C8Q38222606-9770ECB4-A68C-4BA8-9884-DFE20C46CB9CQ46412296-695A69D6-3CC5-44EB-9C10-6156197FF3C2Q59126140-ACCC16BD-1E73-437A-81DC-83C88932E4A8
P2860
15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
15-oxo-Eicosatetraenoic acid, ...... endothelial cell proliferation
@ast
15-oxo-Eicosatetraenoic acid, ...... endothelial cell proliferation
@en
15-oxo-Eicosatetraenoic acid, ...... endothelial cell proliferation
@nl
type
label
15-oxo-Eicosatetraenoic acid, ...... endothelial cell proliferation
@ast
15-oxo-Eicosatetraenoic acid, ...... endothelial cell proliferation
@en
15-oxo-Eicosatetraenoic acid, ...... endothelial cell proliferation
@nl
prefLabel
15-oxo-Eicosatetraenoic acid, ...... endothelial cell proliferation
@ast
15-oxo-Eicosatetraenoic acid, ...... endothelial cell proliferation
@en
15-oxo-Eicosatetraenoic acid, ...... endothelial cell proliferation
@nl
P2093
P2860
P921
P356
P1476
15-oxo-Eicosatetraenoic acid, ...... endothelial cell proliferation
@en
P2093
Ian A Blair
Peijuan Zhu
Sumit J Shah
P2860
P304
P356
10.1124/MOL.109.057489
P577
2009-06-17T00:00:00Z